Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Recommendations on TNFα inhibitor biosimilar use in clinical practice: a comparison of European gastroenterology IBD guidance

Autor: Meijboom, Rosanne W, Barbier, Liese, Druedahl, Louise C, Sarnola, Kati, Tolonen, Hanna M, Gardarsdottir, Helga, Egberts, Toine C G, Giezen, Thijs J

Professional associations publish guidance advising gastroenterologists on prescribing biosimilars; however, guidelines differ between countries and change over time. This study aimed to map the presence and content of guidance from European gastroen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::755421332321dcfa48f167d6d47c6ec1

Incidence of and Reasons and Determinants Associated with Retransitioning from Biosimilar Etanercept to Originator Etanercept

Autor: Meijboom, Rosanne W., Gardarsdottir, Helga, Becker, Matthijs L., ten Wolde, Saskia, Egberts, Toine C.G., Giezen, Thijs J.

Background: Patients in clinical practice are transitioned from originator etanercept (OR-ETA) to biosimilar etanercept (BS-ETA), but some subsequently retransition. Insights into the incidence of and reasons for retransitioning and the characteristi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______101::64e2d6412a571aaf4320f7cdbd18e849
https://dspace.library.uu.nl/handle/1874/413406

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Patients Retransitioning from Biosimilar TNFα Inhibitor to the Corresponding Originator After Initial Transitioning to the Biosimilar: A Systematic Review.

Autor: Meijboom RW; Pharmacy Foundation of Haarlem Hospitals, Haarlem, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands., Gardarsdottir H; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Pharmaceutical Sciences, University of Iceland, Reykjavík, Iceland., Egberts TCG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands., Giezen TJ; Pharmacy Foundation of Haarlem Hospitals, Haarlem, The Netherlands. tgiezen@sahz.nl.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands. tgiezen@sahz.nl.; Department of Clinical Pharmacy, Spaarne Gasthuis, Haarlem and Hoofddorp, The Netherlands. tgiezen@sahz.nl.

Publikováno v: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2022 Jan; Vol. 36 (1), pp. 27-39. Date of Electronic Publication: 2021 Dec 06.